| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/24/2002 | WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 10/24/2002 | WO2002083891A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 10/24/2002 | WO2002083840A2 Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions |
| 10/24/2002 | WO2002083779A1 Improvements in or relating to modified cellulose films |
| 10/24/2002 | WO2002083700A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 10/24/2002 | WO2002083689A1 3,7-diazabicyclo [3.3.1] formulations as anti-arrythmic compounds |
| 10/24/2002 | WO2002083687A1 3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds |
| 10/24/2002 | WO2002083674A2 Compositions containing imidazotriazinone for nasal application |
| 10/24/2002 | WO2002083655A1 Prodrugs of cox-2 inhibitors |
| 10/24/2002 | WO2002083626A2 Alkyl and/or alkenyl glycerol carbamates |
| 10/24/2002 | WO2002083321A1 Aerosol product |
| 10/24/2002 | WO2002083222A1 Device for artificial respiration |
| 10/24/2002 | WO2002083208A2 Implantable therapeutic substance delivery device having a permanent magnet solenoid pump |
| 10/24/2002 | WO2002083207A1 Implantable therapeutic substance delivery device having a piston pump with an anti-cavitation valve |
| 10/24/2002 | WO2002083192A1 Articles comprising a mint odor-free cooling agent |
| 10/24/2002 | WO2002083178A1 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 10/24/2002 | WO2002083177A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine |
| 10/24/2002 | WO2002083170A1 Vaccines including as an adjuvant type 1 ifn and processes related thereto |
| 10/24/2002 | WO2002083166A1 Interferon-polymer complexes and medicinal use thereof |
| 10/24/2002 | WO2002083165A1 Stable preparations for injection |
| 10/24/2002 | WO2002083159A1 Palliative effects of morinda citrifolia oil and juice |
| 10/24/2002 | WO2002083153A1 Method and composition for controlled release acarbose formulations |
| 10/24/2002 | WO2002083135A2 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
| 10/24/2002 | WO2002083132A1 Gastric acid secretion inhibiting composition |
| 10/24/2002 | WO2002083129A2 Pharmaceutical composition comprising clavulanic acid |
| 10/24/2002 | WO2002083121A1 Compositions for improving skin environment and clothes thereof |
| 10/24/2002 | WO2002083118A1 Concentrated aqueous solution of ibuprofen |
| 10/24/2002 | WO2002083113A2 Aerosol compositions containing formoterol and a steroid such as e.g. budesonide or fluticasone for delivery into the lungs via nebulization |
| 10/24/2002 | WO2002083108A2 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application |
| 10/24/2002 | WO2002083107A1 Adhesive emulsion for medical purposes made from ethylene-vinyl acetate copolymers and adhesive resins |
| 10/24/2002 | WO2002083106A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 10/24/2002 | WO2002083105A2 Composition for enhanced absorption of nsaids |
| 10/24/2002 | WO2002083104A1 An effervescent solid composition of matter |
| 10/24/2002 | WO2002083103A2 Pharmaceutical product with reticulated crystalline microstructure |
| 10/24/2002 | WO2002083102A1 Emulsions as solid dosage forms for oral administration |
| 10/24/2002 | WO2002083101A1 Controlled-release nimodipine tablet and method for producing the same |
| 10/24/2002 | WO2002083100A1 Liposomes consisting mainly of cholesterol |
| 10/24/2002 | WO2002083099A1 Pharmaceutical formulations containing anti-inflammatory active ingredients and the use of said formulations |
| 10/24/2002 | WO2002083098A1 Coenzyme q10 containing microemulsion preconcentrates and microemulsions |
| 10/24/2002 | WO2002083097A2 Drug delivery system for hydrophobic drugs |
| 10/24/2002 | WO2002083096A1 Modification of the sustained release profile |
| 10/24/2002 | WO2002083094A1 Fatty acid and glucolipid based improved stability and high viscosity emulsion which can be used in cosmetics |
| 10/24/2002 | WO2002083086A1 Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries |
| 10/24/2002 | WO2002083084A1 Nail compositions and methods of administering same |
| 10/24/2002 | WO2002083079A2 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 10/24/2002 | WO2002082930A1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same |
| 10/24/2002 | WO2002082924A1 Microcapsules |
| 10/24/2002 | WO2002082900A1 Aqeuous suspension of nanoparticles comprising an agrochemical active ingredient |
| 10/24/2002 | WO2002074244A3 Transcutaneous immunostimulation |
| 10/24/2002 | WO2002066078A3 Modulated release particles for aerosol delivery |
| 10/24/2002 | WO2002066077A3 Modulated release particles for aerosol delivery |
| 10/24/2002 | WO2002064557A3 New crystal forms of oxcarbazepine and processes for their preparation |
| 10/24/2002 | WO2002062310B1 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 10/24/2002 | WO2002060409A8 Membrane for encapsulation chamber of cells producing at least a biologically active substance and bioartificial organ comprising same |
| 10/24/2002 | WO2002048380A3 Glycosilated cationic lipids for liposomes used in drug delivery |
| 10/24/2002 | WO2002047729A3 Drug delivery system comprising a drug intercalated between a layered double hidroxide |
| 10/24/2002 | WO2002047667A3 Novel medicament compositions based on anticholinesterase drugs and on a steroid |
| 10/24/2002 | WO2002043700A3 Particles for use in a pharmaceutical composition |
| 10/24/2002 | WO2002034113A3 Methods and instruments for treating pseudoarthrosis |
| 10/24/2002 | WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation |
| 10/24/2002 | WO2002030467A3 Pharmaceutical composition containing honey for the treatment of wounds |
| 10/24/2002 | WO2002015880A8 Powdered mannitol and mannitol-containing compositions |
| 10/24/2002 | WO2001072315A9 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 10/24/2002 | WO2001068135A9 Compositions and methods for affecting osteogenesis |
| 10/24/2002 | WO2001054636A9 Methods and devices for preventing transmission of sexually transmitted diseases |
| 10/24/2002 | US20020156773 Soluble HLA ligand database utilizing predictive algorithms and methods of making and using same |
| 10/24/2002 | US20020156483 Vertebroplasty injection device and bone cement therefor |
| 10/24/2002 | US20020156464 Non-constant pressure infusion pump |
| 10/24/2002 | US20020156463 Drug delivery device |
| 10/24/2002 | US20020156462 Programmable implantable pump with accessory reservoirs and multiple independent lumen catheter |
| 10/24/2002 | US20020156461 Fluid delivery device and associated method |
| 10/24/2002 | US20020156434 Stabilizing catheter for protein drug delivery |
| 10/24/2002 | US20020156383 Cardiac drug delivery system |
| 10/24/2002 | US20020156284 Crystalline form of omeprazole |
| 10/24/2002 | US20020156237 Novel amide-based cationic lipids |
| 10/24/2002 | US20020156133 Oral administration forms for administering a fixed tramadol and diclofenac combination |
| 10/24/2002 | US20020156124 Paclitaxel, a solvent, a surfactant, a substituted cellulosic polymer, and a P-glycoprotein inhibitor; supersaturation of a microemulsion upon contact with water |
| 10/24/2002 | US20020156101 Use for pain management |
| 10/24/2002 | US20020156099 1-acyl-piperidine substance p antagonist; used to treat central nervous system disorders and respiratory diseases |
| 10/24/2002 | US20020156091 Dosing interval of the nimesulide overlaps with that of the oxycodone to reduce the amount of oxycodone needed to provide an effect |
| 10/24/2002 | US20020156072 Thiazine oxazolidinone |
| 10/24/2002 | US20020156066 Preparing a solution of paroxetine hydrochloride or sertaline hydrochloride and a water-soluble carrier in a co-solvent of a volatile solvent and water, and drying the solution |
| 10/24/2002 | US20020156065 Medicament and method for the remediation of aberrant fibrotic tissue masses with topical calcium channel blocker preparations |
| 10/24/2002 | US20020156062 Microaggregates of micelles containing phospholipids and a photosensitizer, and the phospholipids are capable of forming a lipid bilayer |
| 10/24/2002 | US20020156056 Fast-dispersing dosage form of apomorphine and testosterone that disintegrates in the oral cavity within 1-30 seconds |
| 10/24/2002 | US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors |
| 10/24/2002 | US20020156049 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 10/24/2002 | US20020156045 Magnesium chloride improves efficiency of transfection of polynucleotide; drug delivery; vaccination |
| 10/24/2002 | US20020156036 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 10/24/2002 | US20020156029 A kit for treating transient acantholytic dermatitis, acne miliaris necrotica, acne varioliformis, perioral dermatitis, or acneiform eruptions comprising, e.g., ivermectin, and a carrier |
| 10/24/2002 | US20020155997 Biologically active material isolated from non-pathogenic bacteria, such as Enterobacteriaceae |
| 10/24/2002 | US20020155994 Aggregates of human insulin derivatives |
| 10/24/2002 | US20020155993 Especially those derived from two alpha-amino acids independently selected from the group consisting of glutamic acid, aspartic acid, tyrosine, phenylalanine, and optical isomers thereof. |
| 10/24/2002 | US20020155992 Paclitaxel, epipodophyllotoxin, decetaxel, topotecan, and podophyllotoxin covalently conjugated to a polypeptide drug carrier having 50-90% by weight glutamic acid; inproved solubility |
| 10/24/2002 | US20020155986 Use of an AT1 or AT2 receptor antagonist for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors |
| 10/24/2002 | US20020155558 Generation of preferential phosphatides; obtain phosphatide, incubate with phosphatidyl glycerol, incubate phospholipase, recover phosphatide |
| 10/24/2002 | US20020155520 Coating particle with dye; contacting cell; releasing dye |
| 10/24/2002 | US20020155425 Photometric glucose measurement system using glucose-sensitive hydrogel |
| 10/24/2002 | US20020155285 Bio-wave card and sticky piece |
| 10/24/2002 | US20020155175 Natural cell control carrier modular compounded inula helenium L. extract and water-soluble chitosan |